Moms all around the world are asking for information about breastfeeding while taking various drugs. With many drugs, no information is available. The Texas Tech University Health Sciences (TTUHSC) Center Infant Risk Center is conducting a series of online surveys to find out how our information is used, and what if any side effects occur in a breastfeeding infant exposed to specific medications.
We are currently conducting an online survey of women who are breastfeeding while taking Mesalamine. The purpose of the survey is to gather information about side effects the mother and the baby may have experienced as a result of drug exposure. We also ask for basic demographic information and a brief medical history on the mother and baby in hopes of accounting for outside/additional influences that may also have an affect on reported side effects.
Eligible persons include non-pregnant women between 18 and 45 years of age who are currently taking Mesalamine and are breastfeeding OR who have taken Mesalamine while breastfeeding.
Although you will not directly benefit from participation, the information you provide may assist other breastfeeding women in the future. You will not be paid for participating in this survey. TTUHSC is compliant with the Health Insurance Portability and Accountability Act of 1996 (HIPAA) and Texas state laws and regulations for the privacy and security of health information. Your information will not be sold or given to any other agency. Any publication of our findings will not identify any participants individually or in an identifiable manner.
Participation in the research project is entirely optional and all of your answers are confidential. The InfantRisk Center is entirely dedicated to supporting mothers during pregnancy and breastfeeding.
Thomas W. Hale, R.Ph., Ph.D.
Principal Investigator of this Research
Director, The InfantRisk Center
Texas Tech University School of Medicine
Help us help other mothers.
Helping moms one call at a time